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Abstract
Background: Public SNP databases are frequently used to choose SNPs for candidate genes in the association
and linkage studies of complex disorders. However, their utility for such studies of diseases with ethnic-dependent
background has never been evaluated.
Results: To estimate the accuracy and completeness of SNP public databases, we analyzed the allele frequencies
of 41 SNPs in 10 candidate genes for obesity and/or osteoporosis in a large American-Caucasian sample (1,873
individuals from 405 nuclear families) by PCR-invader assay. We compared our results with those from the
databases and other published studies. Of the 41 SNPs, 8 were monomorphic in our sample. Twelve were
reported for the first time for Caucasians and the other 29 SNPs in our sample essentially confirmed the
respective allele frequencies for Caucasians in the databases and previous studies. The comparison of our data
with other ethnic groups showed significant differentiation between the three major world ethnic groups at some
SNPs (Caucasians and Africans differed at 3 of the 18 shared SNPs, and Caucasians and Asians differed at 13 of
the 22 shared SNPs). This genetic differentiation may have an important implication for studying the well-known
ethnic differences in the prevalence of obesity and osteoporosis, and complex disorders in general.
Conclusion: A comparative analysis of the SNP data of the candidate genes obtained in the present study, as well
as those retrieved from the public domain, suggests that the databases may currently have serious limitations for
studying complex disorders with an ethnic-dependent background due to the incomplete and uneven
representation of the candidate SNPs in the databases for the major ethnic groups. This conclusion attests to the
imperative necessity of large-scale and accurate characterization of these SNPs in different ethnic groups.
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Background
A single nucleotide polymorphism (SNP) is generally
defined as a stable substitution of a single base with a fre-
quency of more than 0.01 in at least one population [1].
In human genetic studies, SNPs are simply referred to as
bi-allelic markers since the other types (tri-allelic and
tetra-allelic SNPs) are very rare in the human genome [2].
SNPs have been recognized as an important tool in
human genetics and medicine [3,4]. Because SNPs are
abundant and scattered throughout the whole human
genome, they have been widely used in the genetic associ-
ation studies of various complex diseases such as obesity,
osteoporosis, asthma, hypertension (see, e.g., [5-7]). Var-
ious analyses of SNPs across the human genome have
been also conducted to determine haplotype patterns in
human populations [8-12]. These data are very useful to
study the genetic basis of common complex diseases [13].
At present there are several SNP public databases. The
largest are dbSNP and HGVbase containing together sev-
eral million SNPs [14]. There also exist other relatively
small or specific SNP databases, e.g., TSC [15], JSNP [16],
HOWDY [17], GeneSNPs [18]. While the databases have
been continuously expanded, the quality and complete-
ness of the deposited SNP data remain to be of particular
importance and to be assessed. Recent evaluation of qual-
ity and comprehensiveness of about four million candi-
date SNPs from some public and Celera databases showed
that about 6–12% SNPs could not be validated [19]. They
represent rare variants, population-specific SNPs and
sequencing errors. The other studies reported that only
about 50% SNPs are common in any given population.
Therefore, measurement of allele frequency and linkage
disequilibrium for SNPs in databases should be done to
efficiently select a minimal subset of SNPs for population
association studies of complex diseases [20,21].
Obesity and osteoporosis are common complex disorders
with continuously growing burden and cost for their pre-
vention and treatment. For example, the most recent data
for the United States, derived from the third National
Health and Nutrition Examination Survey (1988–94),
showed ~20% of US men and ~25% of US women are
obese and these proportions are increasing [22]. The same
tendency has been observed in other human populations
[23]. Osteoporosis is another major health problem, par-
ticularly in the elderly. More than 40% of postmenopau-
sal women, on average, will suffer at least one
osteoporotic fracture [24]. This disorder incurred an esti-
mated direct cost of ~14 billion dollars in the USA alone
in 1995 [25].
SNPs of candidate genes for obesity and osteoporosis may
be of particular importance in genetic studies of these dis-
orders. The allele frequencies are important in the selec-
tion of SNPs for studying complex diseases [26]. For
example, association studies of osteoporosis usually gen-
erate inconsistent results in different ethnic groups [27].
One important reason is that polymorphisms associated
significantly with certain osteoporotic phenotypes in a
given ethnic group may be absent or rare in another ethnic
group [28-31]. Moreover, racial differences in the preva-
lence of certain allele could account for certain proportion
of disease trait variation between different ethnicities [32].
Finally, a comparison of SNP allele frequencies among
different ethnicities can provide valuable information for
mapping by admixture linkage disequilibrium (MALD)
[33].
Despite the importance of the above data, no attempts
have been made to check the quality and completeness of
SNPs of candidate genes for obesity and osteoporosis in
the public databases. In fact, most allele frequencies in the
databases were obtained from studies of relative small
samples (dozens or so), which could yield large sampling
errors. In addition to the databases, there are abundant
SNP data from many association/linkage studies of these
two common complex diseases. These individually pub-
lished data have not yet been assessed in reference to each
other, or to those in the databases. In most association
studies, the regular sample sizes used to detect allele fre-
quencies have only been of the order of a hundred or so.
However, to obtain reliable estimates of allele frequency
distributions, relatively larger sample sizes are needed. For
example, for an SNP, to let allele frequency estimate's
|error| = 0.05, the required sample sizes for frequency dis-
tribution (0.5, 0.5), (0.7, 0.3), and (0.9, 0.1) should be at
least 1150, 1000, and 400, respectively [34]. Otherwise,
the estimates of allele frequencies may be biased to a large
extent.
In the present study, we determined allele frequencies of 41
SNPs in 10 candidate genes for obesity and/or osteoporosis
in a large American-Caucasian sample (1,873 subjects from
405 nuclear families). We then compared them with the
corresponding data for the major ethnic groups obtained
from the public databases and various individual studies to
check their accuracy and completeness, and to compare the
SNP allele frequencies in different ethnic groups.
Results
SNP polymorphism in the studied Caucasian sample
Of the 41 candidate SNPs for obesity and/or osteoporosis
identified in the studied Caucasian sample (Table 1), 29
(70.7%) had minor allele frequency ≥0.1. Eight SNPs
(19.5%) were monomorphic. Allele frequencies of twelve
SNPs in Caucasians were reported for the first time (Table
2). Five of these SNPs were monomorphic and the other
seven were polymorphic with minor allele frequencies
ranged 0.019–0.398.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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Table 1: Summary information about the studied SNPs
SNPa Geneb Namec dbSNP 
Accession
Mutationd Domain Minor 
allele 
frequency
Forward primer Reverse primer
1 APOE ss12568587 G-C 5' UTR 0.357 TCCCCAGGAGCCGGTGA CCCCAAGCCCGACCCC
2 APOE ss12568609 G-A Intron 2 0.399 CCTCAGGTGATCTGCCCGTTTC ACTCCTGGGCTCAAGTGATCCTC
3 APOE ss12568607 T-C Exon 4 0.149 CGGGCACGGCTGTCCAA CGAGCATGGCCTGCACCTC
4 APOE ss12568612 C-T Exon 4 0.087 GCTGCGTAAGCGGCTCC GCGGCCCTGTTCCACC
5C O L 1 α1 ss12568606 G-T 5' UTR 0.154 GCACCCTGCCCTAGACCAC CCTAGTGCCAGCGACTGCA
6C O L 1 α1 Sp1 ss12568597 G-T Intron 1 0.188 CCAATCAGCCGCTCCCATTC CATCGGGAGGGCAGGCTC
7C O L 1 α1 ss12568598 G-T Exon 8 0.000 GGAAGACTGGGATGAGGGCA GGCTCGCCAGGCTCACC
8C O L 1 α1 ss12568584 G-A Exon 45 0.019 CTCAGCCTTCCCTGGCCAA AGGCGGAAGTTCCATTGGCATC
9E R - α ss12568579 A-G Exon 1 0.484 TTGAGCTGCGGACGGTTCA CGCCGGTTTCTGAGCCTTC
10 ER-α PvuII ss12568596 T-C Intron 1 0.449 TGGGATTCCAGGCATGAACCAC TGGCGTCGATTATCTGAATTTGGCC
11 ER-α ss12568619 G-A Intron 3 0.257 CCCAGAAACAAGTCATCTGCTATTGACA TGTAACAAAAGGTTAACAATGGTTAGCCC
12 ER-α ss12568618 G-C Exon 4 0.218 ACAGCCTGGCCTTGTCCC CAGGTTGGTCAGTAAGCCCATCA
13 ER-α ss12568585 G-A Intron 4 0.098 GATCAATGAAGTGGGTCTTGAAAAACCAA GGTGACAAGCTGGAAATCTAAGCTTCA
14 ER-α ss12568605 G-A Intron 6 0.119 GGAACGGCCCTTGGAAATTGTAAA CTGCCTACAGAATACAGTCAGCCA
15 ER-α ss12568617 G-A Exon 8 0.203 TCGCATTCCTTGCAAAAGTATTACATCAC CAAGCAAATGAATGGCCACTCATCTAGAAA
16 IL-6 ss12568616 C-G 5' UTR 0.434 GGGCAGAATGAGCCTCAGACATC GACATGCCAAAGTGCTGAGTCACTAATA
17 IL-6 ss12568586 A-T Exon 4 0.005 CCTCCACTGCAAAGGATTTATTCAACA CATGTCCTGCAGCCACTGGTTC
18 LEPR ss12568615 A-G Exon 4 0.290 AGATTTAAGTTGTCTTGCATGCCACC TTAAGCCCAGCATCCATTAGCTATTCTTTC
19 LEPR ss12568604 G-C Exon 14 0.182 GAGTAATTGGAGCAATCCAGCCTACA GCTTCAGCCACTGTACATCTTAGCTC
20 LEPR ss12568614 G-A Exon 20 0.353 GCCACGCTGATCAGCAACTC CCCTTGACTTGTCAGTCAAAAGCAC
21 PTHR1 ss12568589 G-A Intron 1 0.001 GACTTACATTAGGATTCAAGGTTACTGCCA GGGACGCAAGCCTGAGTCC
22 PTHR1 ss12568592 A-G Intron 2 0.398 GCAGAACCCTAAGGGCTTGTCA GGCGGGACCCAGGATACA
23 PTHR1 ss12568591 C-T Intron 8 0.374 CGAGCCTCAATTCAGGTGAATCTAACC CCCGCCCCAAGTGGAACA
24 PTHR1 ss12568588 G-A Intron 10 0.397 CCTTGAGCCCTTGGTTTTCCTTTC GCTCCGGGAACAAAAAGTGGATCA
25 PTHR1 ss12568590 G-A Exon 13 0.380 CTACAAGGCTCAAATTGCCCCAAA TTGGCGTCCACTACATTGTCTTCA
26 TGF-β1 ss12568613 C-T 5' UTR 0.311 GGGCCCAGTTTCCCTATCTGTAAA CTGGGCCACCGTCCTCATC
27 TGF-β1 ss12568603 +C/-C Intron 4 0.021 CCACGCCCCACTTATCTATCCC GGAAAGGCCGGTTCATGCCA
28 TGF-β1 ss12568593 C-T Exon 5 0.008 CAGGCTACAAGGCTCACCTGAA GGTTCACTACCGGCCGC
29 TGF-β1 ss12568602 C-T Intron 5 0.274 GGCTTGTCTTAAGCATTGCGTGAAATTAA GTACAGCTGCCGCACGC
30 TNFR2 ss12568594 T-C 5' UTR 0.000 TGCACTCGGCCTGTTTAGACTC CTGTTCATCTGCCCCCTGCC
31 TNFR2 ss12568611 T-G Exon 6 0.198 AGCCACCCCAGCCACTC GCTTGGAGCAGTGCTGGGTTC
32 UCP3 ss12568601 C-T 5' UTR 0.265 CACTGCCCTCACCAGCCA GTGAGTCCTGCCACGGCA
33 UCP3 ss12568600 G-A Exon 2 0.000 GCCCTAAAGGGACTGGGCA GAAAGGTAACGAGGTCAGCAAAACA
34 UCP3 ss12568595 T-C Exon 3 0.258 TGATTCCCGTAACATCTGGACTTTCATC CTGCCTAAATCCCCTTAGCAGAAAAAAAAA
35 UCP3 ss12568580 T-C Exon 5 0.447 CCTAACAGGAACTTTGCCCAACATCA TCCACGGAGTTCTGGGTTCC
36 UCP3 ss12568599 C-T Exon 7 0.000 CCTAACAGGAACTTTGCCCAACATCA TCCACGGAGTTCTGGGTTCC
37 VDR ss12568583 G-A 5' UTR 0.281 CAGCATGCCTGTCCTCAGC CCAGTACTGCCAGCTCCCA
38 VDR FokI ss12568581 C-T Exon 2 0.373 TGGCCCTGGCACTGACTC GGCACGTTCCGGTCAAAGTC
39 VDR ss12568582 C-T Exon 4 0.000 GGACAGTCTGCGGCCCA CCCTACTCCCTGGGCCC
40 VDR BsmI ss12568610 G-A Intron 8 0.419 GTGCCCCTCACTGCCCTTA CCTCAAATAACAGGAATGTTGAGCCCA
41 VDR TaqI ss12568608 T-C Exon 9 0.408 GGGCCAGGCAGTGGTATCAC AGGTCGGCTAGCTTCTGGATCA
aDesignation in the present study. bAbbreviations: APOE, apolipoprotein E; COL1α1, collagen type I α1; ER-α, estrogen receptor-α; IL-6, interleukin-
6; LEPR, leptin receptor; PTHR1, parathyroid hormone (PTH)/PTH-related peptide receptor type 1; TGF-α1, transforming growth factor-ß1; TNFR2, 
tumor necrosis factor receptor 2; UCP3, uncoupling protein 3; VDR, vitamin D (1,25-dihydroxyvitamin D3) receptor. cCommon name. dMinor alleles 
are given in bold.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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Data on the candidate SNPs for obesity and/or 
osteoporosis from major ethnic groups: an analysis of 
literature and databases
Caucasians
In available literature and public SNP databases, we found
data about allele frequencies of 29 SNPs (representing 9
genes) in Caucasians, which were shared with the present
study. The corresponding data are given in Table 3. The
allele frequencies of only 14 SNPs had been previously
reported for Caucasians to the public databases (dbSNP
and/or HGVbase). No significant differences were found
between the allele frequencies in our study and in the
public databases, except for SNP31 in Australians (P =
0.05, Table 3).
In contrast to the databases, available literature contained
data on allele frequencies of the 23 SNPs. We determined
significant differences between our and literature data for
allele frequencies of four SNPs (SNP16, SNP32, SNP35,
and SNP36). We have not found any allele frequency data
on the SNPs of the PTHR1 gene (SNP21-SNP25) for Cau-
casians. Some SNP indicated large discrepancies in allele
frequencies between the data from the different databases.
For example, the minor allele frequencies of SNP26 for
two Caucasian samples reported to dbSNP and HGVbase
are 0.43 and 0.26, respectively (Table 3). The differences
between the values are not statistically significant due to
the small sample sizes (n = 31 and n = 42, respectively), so
it is impossible to conclude what actual allele frequencies
are in these populations and whether they are indeed sig-
nificantly different.
African/African-Americans
Table 4 presents our SNP data in comparison with the cor-
responding data on African and/or African-American sam-
ples obtained from literature and the databases. In the
public domain, we found in total only 18 SNPs from
seven genes, which are shared with our study. The candi-
date genes for obesity and/or osteoporosis appear to be
underrepresented for Africans/African-Americans in the
public SNP databases and literature: only 11 shared SNPs
were found in the databases and seven in the literature.
Among those, one (SNP36) was monomorphic and four
had minor allele frequency <0.1. Significant differences in
allele frequencies between Caucasians and Africans/Afri-
can-Americans were found at three SNPs (SNP16, SNP34
and SNP35). Three more SNPs (SNP32, SNP33, and
SNP41) manifested nearly significant differences in allele
frequencies between these ethnic groups (Table 4). We
found no data on the SNPs of three genes (COL1α1,
PTHR1, and TNFR2) for Africans/African-Americans in
the public domain, which would be shared with our
study.
Similar to the case with Caucasians, there are large incon-
sistencies between some SNP data for Africans/African-
Americans from the different databases. For example, the
reported minor allele frequencies of SNP26 from the TSC
and dbSNP databases are 0.27 and 0.15, respectively
(Table 4). The former is not significantly different (P =
0.61) from the corresponding value in Caucasians, while
the latter is nearly significantly different (P = 0.07). How-
ever, it is hard to determine, which value is true because of
the small sample sizes (n = 42 and n = 24, respectively) in
the databases.
Asians
As compared to our SNP data, this ethnic group had cor-
responding data on 22 SNPs (8 genes) in the public
domain (Table 5). The data on 13 SNPs of the 6 genes
were available from the public databases, and on 10 SNPs
of the 5 genes were reported in the literature. Among
those SNPs, two (SNP16 and SNP33) were monomorphic
and one (SNP36) had minor allele frequency <0.1. Two
more SNPs of the VDR gene (SNP40 and SNP41) have a
minor allele frequency about this value; however, this fre-
quency varies in different Asian populations. We observed
a significant inconsistency between the values of a minor
allele frequency for SNP40 in Asians from the database
and literature, respectively. In the database, this value
(0.41) is about 3–10 times higher than that reported in
the literature (0.043–0.13).
Table 2: Minor allele frequencies of SNPs firstly reported for 
Caucasians by this study
Gene SNP Database 
or 
referencea
Sample size Minor allele 
frequency
COL1α1 7 [ 5 2 ]                           2 9 2 0 . 0 0 0
COL1α1 8 dbSNP 1,861 0.019
ER-α 14 JSNP 1,861 0.119
IL-6 17 dbSNP 190 0.005
PTHR1 21 JSNP 380 0.001
PTHR1 22 JSNP 1,861 0.398
PTHR1 23 JSNP 1,863 0.374
PTHR1 24 JSNP 1,855 0.397
PTHR1 25 JSNP 1,851 0.380
TNFR2 30 JSNP 281 0.000
VDR 37 JSNP 1,861 0.281
VDR 39 dbSNP 190 0.000
For gene abbreviations and SNP designations see Table 1. aThe source 
of information about the given SNP.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
Page 5 of 15
(page number not for citation purposes)
Table 3: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Caucasians from databases and 
literature
Gene SNP Reference population Database or 
reference
Data from a database or 
reference
Caucasiansa
Frequencyb n Frequency n
APOE 1 American Caucasians [53]                             0.33 220 0.357 1,862 0.48
2 American Caucasians dbSNP 0.33 24 0.399 1,839 0.64
Europeans from North Karelia, Finland dbSNP 0.4 24 0.399 1,839 0.84
3 European-Americans dbSNP 0.12 24 0.149 1,858 0.91
Caucasiansc HGVbase 0.16 152 0.149 1,858 0.81
Europeans from North Karelia, Finland dbSNP 0.23 24 0.149 1,858 0.37
4 European-Americans dbSNP 0.19 24 0.087 1,783 0.16
Caucasiansc HGVbase 0.08 152 0.087 1,783 0.87
Europeans from North Karelia, Finland dbSNP 0.04 24 0.087 1,783 0.25
COL1 α1 5 White women with Spanish ancestors [54]                             0.13 256 0.154 1,856 0.36
6 American Caucasians [31]                             0.187 637 0.188 1,855 0.98
ER-α 9 Australian females [55]                             0.44 125 0.484 1,861 0.39
Greek males [56]                             0.49 50 0.484 1,861 0.95
10 American females [57]                             0.45 253 0.449 1,861 0.96
Finnish females [58]                             0.42 322 0.449 1,861 0.38
11 SANGER 12 DNAs of Caucasian origin dbSNP 0.08 12 0.257 1,857 0.32
12 Australian females [55]                             0.23 120 0.218 1,859 0.84
Slovenian females [59]                             0.3 85 0.218 1,859 0.10
Caucasiansc dbSNP 0.27 31 0.218 1,859 0.59
13 Caucasiansc HGVbase 0.08 42 0.098 1,863 1.00
15 Caucasiansc dbSNP 0.18 31 0.203 1,863 0.90
IL-6 16 Caucasians dbSNP 0.5 31 0.434 1,860 0.58
English [60]                             0.57 2,560 0.434 1,860 <0.01
Italians [61]                             0.45 183 0.434 1,860 0.74
Spaniards [62]                             0.56 118 0.434 1,860 0.01
Finns HGVbase 0.46 400 0.434 1,860 0.37
Finns HGVbase 0.48 50 0.434 1,860 0.62
Finns HGVbase 0.39 42 0.434 1,860 0.68
Finns [63]                             0.45 400 0.434 1,860 0.60
LEPR 18 English males HGVbase 0.27 322 0.290 1,839 0.41
Caucasiansc [64]                             0.28 56 0.290 1,839 0.98
Swedish males [65]                             0.24 284 0.290 1,839 0.09
19 Swedish males [65]                             0.15 284 0.182 1,776 0.21
20 Caucasiansc [64]                             0.38 56 0.353 1,860 0.79
Caucasiansc dbSNP 0.4 42 0.353 1,860 0.64
English males HGVbase 0.36 322 0.353 1,860 0.77
TGF-ß1 26 Caucasiansc dbSNP 0.43 31 0.311 1,840 0.21
Caucasiansc HGVbase 0.26 42 0.311 1,840 0.59
27 Caucasiansc [66]                             0.02 304 0.021 1,863 0.98
28 Danes [66]                             0.027 302 0.008 190 0.33
29 Caucasianc female DZ twins [67]                             0.25 1,802 0.274 1,852 0.08
TNFR2 31 UK Caucasians [68]                             0.23 192 0.198 1,842 0.39
Germans [69]                             0.25 94 0.198 1,842 0.33
Australians HGVbase 0.26 197 0.198 1,842 0.05
UCP3 32 American Caucasians [70]                             0.21 56 0.265 1,767 0.49
Danes [71]                             0.27 857 0.265 1,767 0.85
French [72]                             0.22 894 0.265 1,767 0.01
33 Caucasiansc [73]                             0.01 165 0.000 295 0.44
34 American Caucasians [70]                             0.2 58 0.258 1,862 0.38
35 Caucasiansc [74]                             0.5 501 0.447 1,863 0.04BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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36 Caucasiansc [73]                             0.02 165 0.000 295 0.05
VDR 38 American Caucasians [75]                             0.42 49 0.373 1,861 0.61
English [76]                             0.4 241 0.373 1,861 0.47
Australians [77]                             0.35 43 0.373 1,861 0.87
40 Caucasiansc dbSNP 0.42 107 0.419 1,860 0.94
English females [76]                             0.44 241 0.419 1,860 0.61
Australian males [77]                             0.47 39 0.419 1,860 0.66
Swiss [78]                             0.39 197 0.419 1,860 0.49
French infants [79]                             0.38 589 0.419 1,860 0.07
41 Caucasiansc dbSNP 0.48 31 0.408 1,859 0.51
French [80]                             0.35 99 0.408 1,859 0.33
Australians [81]                             0.41 68 0.408 1,859 0.94
For gene abbreviations and SNP designations see Table 1. a Present study. b Frequency of the allele corresponding to a minor allele in the present 
study. c Caucasians with unidentified ethnic background.
Table 4: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Africans/African- Americans from 
databases and literature
Gene SNP Reference population Database or 
references
Data from a database or 
reference
Caucasiansa P
Frequencyb n Frequency n
APOE 2 African-Americans dbSNP 0.48 24 0.399 1,839 0.52
3 African-Americans dbSNP 0.10 24 0.149 1,858 0.56
4 African-Americans dbSNP 0.04 24 0.087 1,783 0.25
ER-α 11 SANGER 12 DNAs of African-American origin dbSNP 0.08 12 0.257 1,857 0.32
12 African/African-Americans dbSNP 0.27 24 0.218 1,859 0.61
13 TSC panel of African-Americans dbSNP 0.16 40 0.098 1,863 0.27
15 African/African-Americans dbSNP 0.28 23 0.203 1,863 0.42
IL-6 16 African/African-Americans dbSNP 0.96 24 0.434 1,860 <0.01
LEPR 20 TSC panel of African-Americans dbSNP 0.45 42 0.353 1,860 0.25
TGF-ß1 26 TSC panel of African-Americans TSC 0.27 42 0.311 1,840 0.61
African/African-Americans dbSNP 0.15 24 0.311 1,840 0.07
UCP3 32 African-American females [70]                             0.15 57 0.265 1,767 0.07
33 African-Americans [73]                             0.08 18 0.000 295 0.06
34 African-American females [70]                             0.45 63 0.258 1,862 <0.01
35 African-American females [70]                             0.247 73 0.447 1,863 <0.01
African/African-Americans [74]                             0.20 276 0.447 1,863 <0.01
36 African-Americans [70]                             0.00 18 0.000 295 10.00
VDR 38 African-American males [77]                             0.244 37 0.373 1,861 0.15
40 African-American males [77]                             0.312 32 0.419 1,860 0.30
Nigerians [82]                             0.37 93 0.419 1,860 0.41
41 African/African-Americans dbSNP 0.35 24 0.408 1,859 0.71
African-American males [77]                             0.244 39 0.408 1,859 0.06
For gene abbreviations and SNP designations see Table 1. a Present study. b Frequency of the allele corresponding to a minor allele in the present 
study.
Table 3: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Caucasians from databases and 
literature (Continued)BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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Table 5: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Asian populations from databases and 
literature
Gene SNP Reference population Database or 
reference
Data from a database or 
reference
Caucasiansa P
Frequencyb n Frequency n
ER-α 9 Japanese [83]                             0.412 200 0.484 1,861 0.06
Thai females [84]                             0.337 129 0.484 1,861 <0.01
10 Korean males [85]                             0.39 219 0.449 1,861 0.11
Korean females [86]                             0.415 248 0.449 1,861 0.35
Japanese children [87]                             0.431 102 0.449 1,861 0.80
Taiwanese [88]                             0.39 246 0.449 1,861 0.09
Thai females [89]                             0.414 134 0.449 1,861 0.49
11 SANGER 12 DNAs of Asian origin dbSNP 0.36 12 0.257 1,857 0.49
12 Japanese [83]                             0.483 200 0.218 1,859 <0.01
Japanese females [90]                             0.481 306 0.218 1,859 <0.01
13 Japanese JSNP 0.34 744 0.098 1,863 <0.01
TSC panel of unrelated Asians TSC 0.27 32 0.098 1,863 0.01
14 Japanese JSNP 0.296 752 0.119 1,861 <0.01
15 Japanese JSNP 0.18 741 0.203 1,863 0.21
Japanese [83]                             0.21 200 0.203 1,863 0.88
IL-6 16 Chinese [31]                             0.997 147 0.434 1,860 <0.01
Chinese males [31]                             0.998 259 0.434 1,860 <0.01
Japanese [31]                             1.000 388 0.434 1,860 <0.01
LEPR 20 TSC panel of unrelated Asians dbSNP 0.13 42 0.353 1,860 <0.01
Japanese JSNP 0.15 748 0.353 1,860 <0.01
PTHR1 22 Japanese JSNP 0.43 747 0.398 1,861 0.14
23 Japanese JSNP 0.43 748 0.374 1,863 0.01
24 Japanese JSNP 0.44 750 0.397 1,855 0.05
25 Japanese JSNP 0.43 746 0.380 1,851 0.02
TGF-ß1 26 TSC panel of unrelated Asians dbSNP 0.47 36 0.311 1,840 0.06
TNFR2 31 Japanese [91]                             0.113 265 0.198 1,842 <0.01
Thai [92]                             0.127 201 0.198 1,842 0.02
UCP3 33 Asiansc [73]                             0.00 11 0.000 295 10.00
35 Japanese JSNP 0.45 750 0.447 1,863 0.92
36 Asiansc [73]                             0.04 11 0.000 295 0.54
VDR 37 Japanese JSNP 0.23 750 0.281 1,861 0.01
38 Japanese [93]                             0.37 195 0.373 1,861 0.99
40 SANGER 12 DNAs of Asian origin dbSNP 0.41 12 0.419 1,860 0.77
Chinese females (Han nationality) [94]                             0.043 162 0.419 1,860 <0.01
Taiwanese [95]                             0.083 90 0.419 1,860 <0.01
Japanese [93]                             0.13 195 0.419 1,860 0.02
Koreans [96]                             0.055 211 0.419 1,860 <0.01
Thai females [97]                             0.107 84 0.419 1,860 0.01
41 Chinese (Han nationality) [98]                             0.05 223 0.408 1,859 <0.01
Japanese females [99]                             0.135 119 0.408 1,859 <0.01
Koreans [96]                             0.055 120 0.408 1,859 <0.01
For gene abbreviations and SNP designations see Table 1. a Present study. b Frequency of the allele corresponding to a minor allele in the present 
study. c Asians with unidentified ethnic background.BMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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A comparison of our Caucasian sample and the Asian
populations revealed significant differences in allele fre-
quencies of 13 SNPs located in the 6 genes (Table 5).
Another SNP representing the TGF-ß1 gene (SNP26) indi-
cated the nearly significant difference (P = 0.06). No such
differences were observed only in the UCP3 gene.
Hispanic and Pacific Rim populations
These populations had the poorest data on the SNPs from
the databases and literature as compared to the corre-
sponding data from the present study. We found the data
on only seven SNPs of the five candidate genes for His-
panics (Table 6) and five SNPs of the four genes for Pacific
Rim populations (Table 7). SNP33 and SNP36 for the
UCP3 gene were virtually monomorphic in Hispanics,
similar to that in our Caucasian sample, while only one
significant difference in allele frequencies was observed at
SNP16 between these ethnic populations among the
seven compared SNPs (Table 6).
Table 6: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Hispanics from databases and 
literature
Gene SNP Database or 
references
Data from a database or reference Caucasiansa P
Frequencyb n Frequency n
ER-α 12 dbSNP 0.239 23 0.218 1,859 1.00
15 dbSNP 0.196 23 0.203 1,863 1.00
IL-6 16 dbSNP 0.795 22 0.434 1,860 <0.01
TGF-ß1 26 dbSNP 0.413 23 0.311 1,840 0.36
UCP3 33 [73]                             0.00 27 0.000 295 1.00
36 [73]                             0.02 27 0.000 295 1.00
VDR 41 dbSNP 0.348 23 0.408 1,859 0.83
For gene abbreviations and SNP designations see Table 1. aPresent study. bFrequency of the allele corresponding to a minor allele in the present 
study.
Table 7: Comparison of SNP allele frequencies of the studied Caucasian sample with the data on Pacific Rim populations from 
databases
Gene SNP Database Data from a database or reference Caucasiansa P
Frequencyb n Frequency n
ER-α 12 dbSNP 0.478 23 0.218 1,859 0.02
15 dbSNP 0.326 23 0.203 1,863 0.19
IL-6 16 dbSNP 0.957 23 0.434 1,860 <0.01
TGF-ß1 26 dbSNP 0.458 24 0.311 1,840 0.19
VDR 41 dbSNP 0.13 23 0.408 1,859 <0.01
For gene abbreviations and SNP designations see Table 1. aPresent study. bFrequency of the allele corresponding to a minor allele in the present 
studyBMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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No data on the SNPs of the 10 candidate genes for obesity
and/or osteoporosis were found for Pacific Rim popula-
tions in the available literature. All the data presented in
Table 7 were obtained from the dbSNP database. Three
SNPs out of the five differed significantly in the allele
frequencies between Pacific Rim populations and the
Caucasian sample in our study.
Some new candidate SNPs for genetic studies of obesity 
and osteoporosis
In this study, we identified a number of SNPs, which may
be suitable for genetic studies of obesity and osteoporosis.
In particular, the six polymorphic SNPs with minor allele
frequency ≥0.1, which were firstly determined in Cauca-
sians (Table 2), may be used in population association
studies. A number of SNPs with significant variation in
allele frequencies in populations of different ethnicity
may be appropriate for studying a genetic basis of
between-ethnic differences in the rates of obesity and/or
osteoporosis. Examples are SNP34, SNP35, and SNP32
for Caucasians and African-Americans (Table 4) and sev-
eral SNPs located in the ER-α, LEPR, PTHR1, TNFR2, and
VDR genes for Caucasians and Asians (Table 5). Some of
the SNPs may also be candidates for such studies, if their
allele frequencies reported to the databases are validated
by using sufficiently large sample sizes (e.g., SNP26 in
Asians).
Discussion
Ethnic variation of SNP allele frequencies of the candidate 
genes for obesity and/or osteoporosis
We observed significant differences in allele frequencies of
some studied SNPs for Caucasians (SNP16, SNP35,
SNP32, and SNP36, Table 3) between our results and
respective data from the databases and literature. This
may be due to various factors, such as population admix-
ture and relatively smaller sample size in the other studies
[34]. For example, the sample in the present study con-
sisted of the subjects of various ethnic backgrounds (Ger-
man, French, Dutch, Swedish, some Portuguese and
Italian backgrounds) and the relative proportions of these
ethnic groups are not ascertained. In the mixed samples
from other studies, these proportions may be different
that thus influence the allele frequencies to a larger or
lesser extent (e.g., SNP35 and SNP36, Table 3). Likewise,
monoethnic samples may have allele frequencies signifi-
cantly different from those in the mixed samples (e.g.,
SNP16 in English and Spaniards, SNP32 in French, Table
3). Our results showed that major ethnic groups have sig-
nificantly different allele distribution at some SNP mark-
ers of candidate genes for complex disorders. The largest
differences were observed between Asian and Caucasian
populations, namely at 13 SNPs out of 22 compared
(Table 5). Some genes indicated the significant differences
at most SNPs compared (e.g., PTHR1 between Japanese
and Caucasians, Table 5). These results are consistent with
the previously reported data about high differentiation
between Asians and Caucasians at candidate genes for
bone mass [35,36].
Another important finding is the observed significant dif-
ferences between Caucasian and Pacific Rim populations
in SNP allele frequencies of three important candidate
genes for osteoporosis, ER-α, IL-6, and VDR (Table 7).
Interestingly, the respective SNP allele frequencies in
Asian and Pacific Rim populations have very similar val-
ues (Tables 5 and 7). This may suggest that the Pacific Rim
sample from the database has mainly Asian ancestry [37]
or, perhaps there are some implications for an evolution-
ary history of these populations [38]. In any event, much
more comprehensive data should be obtained to clarify
these issues.
There are abundant data about significant between-ethnic
differentiation at loci, which may underlie complex dis-
eases, including obesity and osteoporosis (see, e.g.,
[36,39-41]). Given that there is well-known different inci-
dence of these disorders in various ethnic groups (e.g.,
[42,43]), such genetic differentiation may have an impor-
tant implication for studying a genetic basis of ethnicity-
specific definitions of obesity and osteoporosis.
Another important application of the SNP markers with
high large between-ethnic and small within-ethnic differ-
ences is MALD studies of complex diseases in the admixed
populations with known parental ethnicities [33,44]. Our
results showed that such SNPs exist in the candidate genes
for obesity and osteoporosis. However, the large-scale
screening of the candidate genes is necessary to identify
such markers with sufficient density.
The results of our study suggest that ethnic heterogeneity
of large samples may notably affect the observed allele fre-
quencies. It is supported by the fact that several SNP allele
frequencies of some sufficiently large monoethnic sam-
ples (e.g., SNP16 in English, SNP32 in French) signifi-
cantly differ from those determined in our sample of
mixed Caucasians (Table 3).
SNP databases: current limitations for studying complex 
diseases
Our analyses showed that the SNP databases in their cur-
rent status might have some limitations for studies of
complex disorders, especially in different ethnic groups,
due to incomplete and/or uneven representation of SNPs
and/or candidate genes in these groups. As indicated
above, of the ten candidate genes examined here, only
four have corresponding but incomplete SNP data in the
databases for all the major ethnic groups and may be used
in the comparative studies of obesity and/or osteoporosisBMC Genetics 2004, 5 http://www.biomedcentral.com/1471-2156/5/4
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in the populations of different ethnicity. The SNP data in
the databases for the other six genes (60% examined)
need substantial updating. To do this, large-scale studies
should be performed for the other major ethnic popula-
tions. Given that many complex diseases have different
rates in different ethnic groups, the extensive volume of
the SNP data needs to be updated and validated. This con-
clusion essentially corresponds to the recently reported
results of the SNP databases evaluation regarding their use
for whole-genome association studies in humans [21].
Our study provides an example showing the incomplete-
ness of the SNP data in the current databases for studying
complex disorders with an ethnic-dependent background.
Another important problem is inconsistency of the data
for some SNP markers between either the different data-
bases or databases and literature. It makes selection of a
right SNP for a study rather difficult. For example, a SNP
is usually considered to be appropriate for association or
linkage studies, if its minor allele frequency is ≥0.1
[45,46]. Based on the data of SNP11 from the dbSNP
database (Table 3), this SNP is hardly appropriate for the
studies in Caucasians, because its minor allele frequency
is 0.08. In fact, as determined in the present study, its
actual frequency is 0.257 that makes this SNP suitable for
the population association and linkage research.
In terms of well-known ethnic differences in incidence of
some complex diseases, the discrepancies in the SNP data-
base data may yield wrong conclusion about suitability of
particular SNPs for studying genetic basis of these differ-
ences. For example, as was mentioned above, SNP26 from
the TGF-ß1 gene has the reported minor allele frequency
0.43 (dbSNP) and 0.26 (HGVbase) for Caucasians, 0.27
(TSC) and 0.15 (dbSNP) for African-Americans, and 0.47
(dbSNP) for Asians (Tables 3,4,5). This gene is a candi-
date for bone mineral density [47] and, thus, may contrib-
ute to the ethnic differences in bone mass and
osteoporosis. However, from the above data on the SNP
allele frequencies, it is impossible to infer whether this
particular SNP may be related to these ethnic differences
in bone mass, because none of the values significantly dif-
fer from any other due to small sample size and, accord-
ingly, limited statistical power.
Large discrepancies in some allele frequency data between
the different databases (e.g., SNP4 for Caucasians) are
likely due to small sample sizes and respective large sam-
pling errors of the estimates. The sample sizes in the SNP
databases are usually smaller than 50. With such a sample
size, a relative sampling error of the allele frequency esti-
mates ranges from 0.12 to 0.67 (fig. 1). In this term, the
estimates of the SNP allele frequencies in the present
study with the sample size of 1,873 are far more reliable
than the respective data from the most databases. Estima-
tion of allele frequencies in small samples is notably
affected by heterogeneity of the samples. Given that infor-
mation about an ethnic background of the samples in the
SNP databases is usually scarce, the allele frequency esti-
mates in the databases may be significantly biased due to
the ethnic admixture.
The small size of the samples in the databases makes it dif-
ficult to powerfully test differences in SNP allele frequen-
cies (∆f) between the data from various sources, especially
if absolute values of these differences are not large. Fig. 2
illustrates a statistical power of such estimation. Given
two samples of size 50 each, the probability to correctly
determine ∆f = 0.1 is only 27% (fig. 2A). Having a sample
size of 1,800 (similar to ours) increases this probability
only up to 40% (fig. 2B). Even a 3-fold difference in the
absolute values (e.g., SNP11, Table 4) is not statistically
significant due to the insufficient sample size in the data-
bases. These examples suggest that some differences in
SNP allele frequency data in the public databases may
exist due to improper sampling or too small sample sizes
[34]. These inconsistencies may be somewhat reduced by
pooling the samples. However, this should be done with
caution, because pooling data from small samples with a
particular genetic background may introduce a large bias
to the new values.
Relative sampling error of different minor allele frequencies  under various sample sizes Figure 1
Relative sampling error of different minor allele fre-
quencies under various sample sizes. The relative sam-
pling error is obtained as  , where   is the 
variance of estimated allele frequencies and is computed as 
[51]. We plotted relative sampling 
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Furthermore, in many cases, even after pooling, the sam-
ple size may remain too small to gain sufficient reliability
of the newly obtained allele frequencies.
The SNP data in literature may somewhat supplement
those from the databases. They are sometimes obtained
with larger samples and, therefore, have smaller sampling
error. However, they are not systematized, which makes
their collection and use difficult.
In conclusion, our study demonstrated that, although a
large volume of SNP data is available in public databases
and literature, a great portion of these data needs compre-
hensive updating and validating in order to be appropri-
ate for genetic studies of complex disorders, such as
obesity and/or osteoporosis. Such large-scale studies of
the disease-associated SNPs in various ethnicities may
provide important insights into the evolutionary history




All the study subjects came from ongoing genetic studies
of complex traits that have been approved by the
Creighton University Institutional Review Board. All the
subjects were Caucasians of western or northern European
origin (German, French, Dutch, Swedish), but some had
Portuguese and Italian backgrounds. We have recruited
405 nuclear families, each composed of both parents and
at least one child. The total sample size was 1,873 sub-
jects, including 840 parents and 1,133 children. All
individuals volunteered to participate in the research and
signed informed-consent documents before entering the
project.
The study SNPs
The candidate SNPs and genes for the present study were
selected from publicly available sources based on some of
the following criteria: 1) functional relevance and impor-
tance for obesity and/or osteoporosis; 2) degree of heter-
ozygosity, i.e., allele frequencies, as reported in literature
or databases; 3) position in or around the genes; and 4)
their use in previous genetic epidemiology studies. After
searching public SNP databases (dbSNP, JSNP, HGVbase,
and TSC) and literature, we chose 41 SNPs in 10 genes
shown to be associated with obesity and/or osteoporosis.
The information about the SNPs is given in Table 1.
Among them, SNP27 is an insertion/deletion
polymorphism of a cytosine (+/- C) and the others are
nucleotide substitutions.
SNP genotyping
DNA was extracted from whole blood using a commercial
isolation kit (Gentra Systems, Minneapolis, MN, USA)
following the procedure recommended by the manufac-
turer. The genotyping involved a polymerase chain reac-
tion (PCR) and invader assay (Third Wave Technology,
Power to detect differences in allele frequencies between two samples at P = 0.05 Figure 2
Power to detect differences in allele frequencies between two samples at P = 0.05. Since the power depends on the 
sample sizes of the two populations, we fixed one population at a sample size of n, while allowing another population to vary in 
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Madison, WI, USA) and was essentially the same for all
the SNPs. The PCR mix consisted of 35 ng genomic DNA,
0.2 mM each dNTP, 1 × PCR buffer and 1.5 mM MgCl2,
0.4 µM each primer, and 0.35 units of Taq polymerase
(ABI Applied Biosystems, Foster City, CA, USA) in a total
10 µl reaction volume. The PCR primers for all SNPs are
given in Table 1. The PCR was performed on PE9700 Ther-
mal Cycler (Perkin Elmer Cetus, Norwalk, CT) using the
following profile: 95°C for 5 min, 30 cycles of 94°C for 1
min, 50°C for 1 min, 72°C for 1 min, and then 72°C for
5 min. After the amplification, the product was diluted
1:20 in nuclease-free water. The invader reaction was car-
ried out in 7.5 µl reaction volume containing 3.75 µl
diluted PCR product, 1.5 µl probe mix, 1.75 µl Cleavase
FRET mix, and 0.5 µl Cleavase enzyme/MgCl2 solution
(Third Wave Technology). The reaction mix was overlaid
by 15 µl mineral oil and denatured at 95°C for 5 min, and
then incubated at 63°C for 20 min on PE9700 Thermal
Cycler. After the incubation, the fluorescence intensity for
both colors (FAM dye and Red dye) was measured by
Cytofluor 4000 (ABI). The data were then loaded to the
Invader Analyzer software (Third Wave Technology), and
the genotype for every sample was called according to the
ratio of the fluorescence intensity of the two dyes.
We initially genotyped all the 41 SNPs in a random sam-
ple of 190 to 380 subjects to find SNPs with minor allele
frequencies <0.01. Those were then excluded from the fur-
ther genotyping. Finally, 33 SNPs were genotyped for the
whole sample.
Data analysis
PedCheck software [48] was used to verify the accuracy of
SNP genotyping in reference to Mendelian inheritance of
the alleles within each family. For the 29 polymorphic
SNPs the allele frequencies in the nuclear families were
estimated by maximum-likelihood method [49] imple-
mented in SOLAR http://www.sfbr.org/sfbr/public/soft
ware/solar. This method uses all available marker infor-
mation by accounting the dependence between relatives.
Differences in allele frequencies of each SNP among vari-
ous populations were tested using the χ2 test or Fisher's
exact two-tailed test as implemented in Advisor software
[50]. SNPs with minor allele frequency less than 0.01 were
considered to be monomorphic.
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